We are live on
!
Find out more
Mirae Asset Global Investments Portfolio holdings
AUM
$67.7B
1-Year Est. Return
57.61%
This Fund
S&P 500
This Quarter
Est. Return
-4.27%
1 Year Est. Return
+57.61%
3 Year Est. Return
+150.9%
5 Year Est. Return
+201.56%
10 Year Est. Return
+1,018.7%
AUM
$24.5B
AUM Growth
-$123M
(-0.5%)
Cap. Flow
+$15.2B
Cap. Flow
% of AUM
62.04%
Top 10 Holdings %
Top 10 Hldgs %
35.31%
Holding
1,687
New
95
Increased
1,038
Reduced
411
Closed
99
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$4.51B |
| 2 |
MakeMyTrip
MMYT
|
+$2.46B |
| 3 |
Trip.com Group
TCOM
|
+$797M |
| 4 |
Yum China
YUMC
|
+$544M |
| 5 |
Alibaba
BABA
|
+$490M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$88.7M |
| 2 |
Pfizer
PFE
|
+$81.1M |
| 3 |
Blackrock
BLK
|
+$71.8M |
| 4 |
US Bancorp
USB
|
+$51.4M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$33.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.26% |
| 2 | Consumer Discretionary | 9.29% |
| 3 | Communication Services | 9.15% |
| 4 | Healthcare | 7.13% |
| 5 | Financials | 5.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1451
Braskem
BAK
$813M
| $12.3K | ﹤0.01% |
3,111
+199
| +7% | +$827 |
|
|
OLP
1452
One Liberty Properties
OLP
$523M
| $12.1K | ﹤0.01% |
462
-14
| -3% | -$366 |
|
1453
Entrada Therapeutics
TRDA
$299M
| $12K | ﹤0.01% |
1,258
+12
| +1% | +$150 |
|
1454
Steven Madden
SHOO
$3.49B
| $11.7K | ﹤0.01% |
440
+93
| +27% | +$3.27K |
|
|
DHC
1455
Diversified Healthcare Trust
DHC
$2.02B
| $11.3K | ﹤0.01% |
4,562
-137
| -3% | -$338 |
|
1456
Maravai LifeSciences
MRVI
$861M
| $11.1K | ﹤0.01% |
4,688
-39
| -0.8% | -$154 |
|
1457
Allogene Therapeutics
ALLO
$714M
| $10.9K | ﹤0.01% |
7,016
+29
| +0.4% | +$55 |
|
|
ATXS
1458
DELISTED
Astria Therapeutics
ATXS
| $10.9K | ﹤0.01% |
1,906
+25
| +1% | +$175 |
|
|
HPP
1459
Hudson Pacific Properties
HPP
$777M
| $10.8K | ﹤0.01% |
518
+11
| +2% | +$230 |
|
1460
Solid Biosciences
SLDB
$971M
| $10.8K | ﹤0.01% |
2,490
+1,159
| +87% | +$4.96K |
|
1461
Amylyx Pharmaceuticals
AMLX
$2.6B
| $10.7K | ﹤0.01% |
2,930
+646
| +28% | +$2.3K |
|
1462
Personalis
PSNL
$1.52B
| $10.7K | ﹤0.01% |
2,953
+599
| +25% | +$2.85K |
|
|
API
1463
Agora
API
$379M
| $10.6K | ﹤0.01% |
+2,436
| New | +$12.7K |
|
1464
Liberty Live Group Series C
LLYVK
$9.8B
| $10.6K | ﹤0.01% |
158
+2
| +1% | +$143 |
|
1465
Rigel Pharmaceuticals
RIGL
$782M
| $10.5K | ﹤0.01% |
589
+2
| +0.3% | +$41 |
|
1466
Pacific Biosciences
PACB
$345M
| $10.5K | ﹤0.01% |
9,237
+111
| +1% | +$170 |
|
1467
Aura Biosciences
AURA
$802M
| $10.5K | ﹤0.01% |
1,656
-9
| -0.5% | -$68 |
|
1468
Arcturus Therapeutics
ARCT
$216M
| $10.5K | ﹤0.01% |
906
+3
| +0.3% | +$48 |
|
1469
Monte Rosa Therapeutics
GLUE
$1.36B
| $10.5K | ﹤0.01% |
2,056
+9
| +0.4% | +$55 |
|
1470
Absci
ABSI
$1.61B
| $10.4K | ﹤0.01% |
3,843
+16
| +0.4% | +$59 |
|
1471
Olema Pharmaceuticals
OLMA
$913M
| $10.2K | ﹤0.01% |
2,484
+575
| +30% | +$2.89K |
|
1472
Aquestive Therapeutics
AQST
$531M
| $9.62K | ﹤0.01% |
3,184
+146
| +5% | +$442 |
|
|
AUTL
1473
Autolus Therapeutics
AUTL
$564M
| $9.61K | ﹤0.01% |
5,790
-865
| -13% | -$1.76K |
|
|
ESPR
1474
DELISTED
Esperion Therapeutics
ESPR
| $9.59K | ﹤0.01% |
6,396
-170
| -3% | -$313 |
|
|
TECX
1475
Tectonic Therapeutic
TECX
$720M
| $9.32K | ﹤0.01% |
500
+8
| +2% | +$261 |
|
Similar funds
Mirae Asset Global Investments's Q1 2025 Portfolio in Review
As of Q1 2025, Mirae Asset Global Investments held 1,687 positions worth $24.5B, down 0.5% from $24.6B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Mirae Asset Global Investments deployed $15.2B of net new capital in Q1 2025, opening 95 new positions and adding to 1,038 existing holdings. Its largest new stake was State Street SPDR Portfolio S&P 500 Value ETF: 320,000 shares worth $16.3M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $88.7M trimmed.
- Mirae Asset Global Investments's largest Q1 2025 buy was State Street SPDR Portfolio S&P 500 Value ETF: 320,000 shares worth $16.3M.
- Mirae Asset Global Investments added most to Pinduoduo in Q1 2025, an estimated $4.51B increase.
- Mirae Asset Global Investments's biggest Q1 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $88.7M.
- Mirae Asset Global Investments fully exited State Street Utilities Select Sector SPDR ETF in Q1 2025, selling an estimated $8.71M.
- Mirae Asset Global Investments's ten largest holdings make up 35% of its $24.5B portfolio in Q1 2025.
- Mirae Asset Global Investments opened 95 new positions and closed 99 in Q1 2025.
- Mirae Asset Global Investments's portfolio value fell 0.5% quarter-over-quarter to $24.5B.
Based on Mirae Asset Global Investments's 13F filing for Q1 2025, filed 24 Apr 2025.